Curis, Inc.
🏢 View company profile →142Patents
81Active
142Granted
54Portfolio score
Filing activity: Jun 16, 1994 → Jan 17, 2024 · 28 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6613798B1 | Small organic molecule regulators of cell proliferation | Chemistry; Metallurgy | 159 | Expired |
| US6326201A | Pancreatic progenitor cells, methods and uses related thereto | Emerging Cross-Sectional Technologies | 125 | Expired |
| US7115653B2 | Small organic molecule regulators of cell proliferation | Chemistry; Metallurgy | 110 | Expired |
| US6683192B2 | Small organic molecule regulators of cell proliferation | Chemistry; Metallurgy | 71 | Expired |
| US6291516A | Regulators of the hedgehog pathway, compositions and uses related thereto | Human Necessities | 57 | Expired |
| US6552016B1 | Mediators of hedgehog signaling pathways, compositions and uses related thereto | Human Necessities | 50 | Expired |
| US6861404B1 | Therapies for chronic renal failure | Human Necessities | 45 | Expired |
| US6498142B1 | Morphogen treatment for chronic renal failure | Human Necessities | 35 | Expired |
| US7396809B1 | Methods and reagents for treating glucose metabolic disorders | Human Necessities | 34 | Expired |
| US6683108B1 | Agonists of hedgehog signaling pathways and uses related thereto | Chemistry; Metallurgy | 34 | Expired |
| US6686388B2 | Regulators of the hedgehog pathway, compositions and uses related thereto | Human Necessities | 31 | Expired |
| US7300929B2 | Mediators of hedgehog signaling pathways, compositions and uses related thereto | Human Necessities | 27 | Expired |
| US6565843B1 | Protein-induced tissue morphogenesis | Physics | 27 | Expired |
| US6531445B1 | Protein-induced morphogenesis in liver tissue | Physics | 26 | Expired |
| US6333312A | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases | Physics | 23 | Expired |
| US8357368B2 | Methods of treating pancreatic or liver cancer using hedgehog antagonists | Chemistry; Metallurgy | 22 | Active |
| US8461157B2 | Phosphoinositide 3-kinase inhibitors with a zinc binding moiety | Chemistry; Metallurgy | 22 | Active |
| US6407060B1 | Method for enhancing functional recovery following central nervous system ischemia or trauma | Human Necessities | 22 | Expired |
| US6207804A | Genetically engineered antibody analogues and fusion proteins thereof | Chemistry; Metallurgy | 22 | Expired |
| US7147839B2 | Methods for evaluating tissue morphogenesis and activity | Physics | 22 | Expired |
| US8563741B2 | CDK inhibitors containing a zinc binding moiety | Chemistry; Metallurgy | 22 | Active |
| US6495513B1 | Morphogen-enhanced survival and repair of neural cells | Physics | 21 | Expired |
| US7498304B2 | Angiogenesis-modulating compositions and uses | Chemistry; Metallurgy | 19 | Expired |
| US8367663B2 | Phosphoinositide 3-kinase inhibitors with a zinc binding moiety | Chemistry; Metallurgy | 15 | Active |
| US6723698B2 | Methods and compositions for the treatment of motor neuron injury and neuropathy | Physics | 15 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.